Pfizer PFE, -2.20% is the latest pandemic stock to face questions about its long-term strategy as revenue from its COVID-19 vaccine and antiviral business starts…
Shares of Oric Pharmaceuticals Inc. ORIC, +59.67% soared about 56% in premarket trading on Thursday, the day after the company said it will collaborate with…
